Pricing Breakdown Lab work is included but not required
For some patients, especially those with genetic predisposition to weight cycling or strong family history, long-term low-dose therapy may be safer and more cost-effective than stopping and restarting
Side effects and results vary
What are the potential side effects from Semaglutide w/niacinimide and Tirzepatide w/niacinimide
True fat regain follows a predictable timeline based on discontinuation studies: 15-20% weight regain in months 1-3, another 20-30% in months 4-9, plateauing around 70-80% total regain by 12-18 months
Obesity care, GLP-1s and the new equation for plan sponsors GLP-1s are transforming obesity care, and the decisions plan sponsors make will impact their organizations for years to come Daniel Cusator , MD, MBA, Account Medical Director, Blue Cross Blue Shield of Tennessee Shane Lipp , Senior Benefits Manager, Synovus Claire Morrow , PT, DPT, OCS, FAAOMPT, Physical Therapy Consultant Senior Manager, Hinge Health Charlie Smith , MD, Chief Medical Officer, AON Gabrielle Boisvert , Head of Solution Strategy, Teladoc Health (Moderator) In 2021, it was the beginning of the widespread, mainstream use of GLP-1s for weight loss
